NCT06956040 Involvement of General Practitioners in Lung Cancer Screening
| NCT ID | NCT06956040 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-06-02 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2025-06-02 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective is to evaluate the adherence of smoking patients to lung cancer screening by low-dose CT scan, when proposed by the general practitioner.
Eligibility Criteria
Inclusion Criteria : * Adults aged 50-74 * Active smoker or weaned smoker for less than 15 years, of at least 20 pack-years * Affiliation with a social security scheme or CMU (beneficiary or beneficiary entitled) * Written informed consent prior to study participation Exclusion Criteria : * History of lung cancer * Thoracic CT scan performed within the previous year * 1-year follow-up not possible * Inability to travel independently to Hôpital Cochin or Hôpital Bichat for scans * People with severe co-morbidities contraindicating exploration and/or management of lung cancers * People in poor general health (=PS2 and above) * People with a history of cancer under active surveillance by thoracic computed tomography (CT and PET scans) * People with rest dyspnea (=mMRC4) * Recent weight loss, altered general condition or hemoptysis, raising suspicion of progressive lung cancer * Signs of respiratory infection (fever, productive cough) * Patients under guardianship, curatorship or protected adults * Inability to give free written informed consent prior to study participation
Contact & Investigator
Céline BUFFEL du VAURE, PhD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT06956040 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 74 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06956040 currently recruiting?
Yes, NCT06956040 is actively recruiting participants. Contact the research team at celine.buffel-du-vaure@u-paris.fr for enrollment information.
Where is the NCT06956040 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06956040 clinical trial?
NCT06956040 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Céline BUFFEL du VAURE, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.